OverviewSuggest Edit

SeaSpine is a medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures.
TypePublic
Founded2015
HQCarlsbad, US
Websiteseaspine.com
Employee Ratings3

Latest Updates

Employees (est.) (Feb 2019)327
Job Openings26
Revenue (FY, 2019)$159.1 M(+11%)
Share Price (Nov 2020)$13.8
Cybersecurity ratingBMore

Key People/Management at SeaSpine

Keith C. Valentine

Keith C. Valentine

President, Chief Executive Officer and Director
Stuart M. Essig

Stuart M. Essig

Lead Independent Director
John J. Bostjancic

John J. Bostjancic

Senior Vice President, Chief Financial Officer
Keith Bradley

Keith Bradley

Director
Dennis Cirino

Dennis Cirino

Senior Vice President, Spinal Systems
Kimberly Commins-Tzoumakas

Kimberly Commins-Tzoumakas

Director
Show more

SeaSpine Office Locations

SeaSpine has an office in Carlsbad
Carlsbad, US (HQ)
5770 Armada Dr
Show all (1)

SeaSpine Financials and Metrics

SeaSpine Revenue

Embed Graph
View revenue for all periods
SeaSpine's revenue was reported to be $159.08 m in FY, 2019
USD

Revenue (Q2, 2020)

28.6m

Gross profit (Q2, 2020)

16.9m

Gross profit margin (Q2, 2020), %

59.2%

Net income (Q2, 2020)

(13.7m)

EBIT (Q2, 2020)

(13.7m)

Market capitalization (20-Nov-2020)

382.2m

Closing stock price (20-Nov-2020)

13.8

Cash (30-Jun-2020)

75.3m

EV

320.5m
SeaSpine's current market capitalization is $382.2 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

133.2m128.9m131.8m143.4m159.1m

Revenue growth, %

(3%)

Cost of goods sold

61.1m55.5m51.8m56.0m58.0m

Gross profit

72.1m73.3m80.0m87.5m101.1m
Quarterly
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

33.4m14.6m10.8m24.2m20.2m

Accounts Receivable

11.0m21.9m20.3m24.9m

Prepaid Expenses

2.0m2.9m3.9m

Inventories

51.3m45.3m41.7m42.7m47.2m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(55.5m)(43.2m)(32.1m)(33.5m)(39.3m)

Depreciation and Amortization

12.4m11.8m10.9m10.7m10.3m

Inventories

(8.4m)1.4m1.2m(3.5m)(5.9m)

Accounts Payable

5.8m(5.0m)(2.1m)1.9m(1.5m)
USDQ2, 2015

Financial Leverage

1.1 x
Show all financial metrics

SeaSpine Operating Metrics

FY, 2016

Patents Issued

3
Show all operating metrics

SeaSpine Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

SeaSpine Online and Social Media Presence

Embed Graph

SeaSpine News and Updates

SeaSpine to Participate in Three Upcoming Investor Conferences

CARLSBAD, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in three upcoming virtual investor conferences.

SeaSpine Research to Feature at Multiple NASS Podium Presentations

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at s…

SeaSpine Announces Limited Commercial Launch of WaveForm C 3D-Printed Interbody Implant System

CARLSBAD, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its WaveForm C Interbody Implant System. Wave…

SeaSpine Reports Granting of Inducement Awards

CARLSBAD, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to eleven non-executive employees.

Kuros Biosciences Signs Agreement to Supply SeaSpine with Bone Graft Incorporating Kuros’s Advanced Submicron Surface Technology

SCHLIEREN (ZURICH), Switzerland, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has signed a private label Original Equipment Manufacturer (OEM) agreement with SeaSpine Holdings Corporation (NASDAQ: SPNE), a global m…

SeaSpine Prices Public Offering of Common Stock

CARLSBAD, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwrit…
Show more

SeaSpine Blogs

SeaSpine® Reports Third Quarter 2020 Financial Results

CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2020. Summary of Third …

SeaSpine® to Participate in Three Upcoming Investor Conferences

CARLSBAD, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in three upcoming virtual investor conferences. Event…

SeaSpine® Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)

Study shows cells in cellular bone matrix products did not improve fusion SeaSpine’s DBM outperformed the tested CBM productsCARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the trea…

SeaSpine® to Report Third Quarter 2020 Financial Results on November 9, 2020

CARLSBAD, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on…

SeaSpine® Research to Feature at Multiple NASS Podium Presentations

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at scie…

SeaSpine® Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2020 and provided a revenue…
Show more

SeaSpine Frequently Asked Questions

  • When was SeaSpine founded?

    SeaSpine was founded in 2015.

  • Who are SeaSpine key executives?

    SeaSpine's key executives are Keith C. Valentine, Stuart M. Essig and John J. Bostjancic.

  • How many employees does SeaSpine have?

    SeaSpine has 327 employees.

  • What is SeaSpine revenue?

    Latest SeaSpine annual revenue is $159.1 m.

  • What is SeaSpine revenue per employee?

    Latest SeaSpine revenue per employee is $486.5 k.

  • Who are SeaSpine competitors?

    Competitors of SeaSpine include Medartis Holding, Livanova and Safe Orthopaedics.

  • Where is SeaSpine headquarters?

    SeaSpine headquarters is located at 5770 Armada Dr, Carlsbad.

  • Where are SeaSpine offices?

    SeaSpine has an office in Carlsbad.

  • How many offices does SeaSpine have?

    SeaSpine has 1 office.